Found: 20
Select item for more details and to access through your institution.
Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope.
- Published in:
- Rheumatology Advances in Practice, 2023, v. 7, n. 3, p. 1, doi. 10.1093/rap/rkad093
- By:
- Publication type:
- Article
Early intervention in systemic lupus erythematosus: time for action to improve outcomes and health-care utilization.
- Published in:
- Rheumatology Advances in Practice, 2022, v. 6, n. 1, p. 1, doi. 10.1093/rap/rkab106
- By:
- Publication type:
- Article
The role of ultrasound in assessing musculoskeletal symptoms of systemic lupus erythematosus: a systematic literature review.
- Published in:
- Rheumatology, 2016, v. 55, n. 3, p. 485, doi. 10.1093/rheumatology/kev343
- By:
- Publication type:
- Article
Efficacy and safety of obinutuzumab in systemic lupus erythematosus patients with secondary non-response to rituximab.
- Published in:
- Rheumatology, 2022, v. 61, n. 12, p. 4905, doi. 10.1093/rheumatology/keac150
- By:
- Publication type:
- Article
Ultrasound to identify systemic lupus erythematosus patients with musculoskeletal symptoms who respond best to therapy: the US Evaluation For mUsculoskeletal Lupus longitudinal multicentre study.
- Published in:
- Rheumatology, 2021, v. 60, n. 11, p. 5194, doi. 10.1093/rheumatology/keab288
- By:
- Publication type:
- Article
Real-world experience of effectiveness of non-medical switch from originator to biosimilar rituximab in rheumatoid arthritis.
- Published in:
- Rheumatology, 2021, v. 60, n. 8, p. 3679, doi. 10.1093/rheumatology/keaa834
- By:
- Publication type:
- Article
Effect of rituximab or tumour necrosis factor inhibitors on lung infection and survival in rheumatoid arthritis-associated bronchiectasis.
- Published in:
- Rheumatology, 2020, v. 59, n. 10, p. 2838, doi. 10.1093/rheumatology/kez676
- By:
- Publication type:
- Article
Defining inflammatory musculoskeletal manifestations in systemic lupus erythematosus.
- Published in:
- Rheumatology, 2019, v. 58, n. 2, p. 304, doi. 10.1093/rheumatology/key277
- By:
- Publication type:
- Article
Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years' experience at a single centre.
- Published in:
- Rheumatology, 2017, v. 56, n. 8, p. 1348, doi. 10.1093/rheumatology/kex072
- By:
- Publication type:
- Article
Primary myocardial disease in scleroderma--a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Group cardiac working group.
- Published in:
- Rheumatology, 2017, v. 56, n. 6, p. 882, doi. 10.1093/rheumatology/kew488
- By:
- Publication type:
- Article
Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome.
- Published in:
- ACR Open Rheumatology, 2022, v. 4, n. 8, p. 689, doi. 10.1002/acr2.11466
- By:
- Publication type:
- Article
Gene Expression and Autoantibody Analysis Revealing Distinct Ancestry‐Specific Profiles Associated With Response to Rituximab in Refractory Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 5, p. 697, doi. 10.1002/art.42404
- By:
- Publication type:
- Article
Reply.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
B Cell Tetherin: A Flow Cytometric Cell‐Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 5, p. 769, doi. 10.1002/art.41187
- By:
- Publication type:
- Article
Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases.
- Published in:
- Arthritis & Rheumatology, 2019, v. 71, n. 11, p. 1812, doi. 10.1002/art.40937
- By:
- Publication type:
- Article
Brief Report: Responses to Rituximab Suggest B Cell-Independent Inflammation in Cutaneous Systemic Lupus Erythematosus.
- Published in:
- Arthritis & Rheumatology, 2015, v. 67, n. 6, p. 1586, doi. 10.1002/art.39085
- By:
- Publication type:
- Article
Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-19918-z
- By:
- Publication type:
- Article
A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.803175
- By:
- Publication type:
- Article
Choosing the Right Rituximab Dose for the Right Patient: Comment on the Article by Bredemeier et al.
- Published in:
- Arthritis Care & Research, 2014, v. 66, n. 10, p. 1591, doi. 10.1002/acr.22379
- By:
- Publication type:
- Article
Biologics in systemic lupus erythematosus: current options and future perspectives.
- Published in:
- British Journal of Hospital Medicine (17508460), 2014, v. 75, n. 8, p. 440, doi. 10.12968/hmed.2014.75.8.440
- By:
- Publication type:
- Article